These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 33558131

  • 1. The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy.
    Li J, Liu B.
    Cytokine Growth Factor Rev; 2021 Apr; 58():75-81. PubMed ID: 33558131
    [Abstract] [Full Text] [Related]

  • 2. C5a and pain development: An old molecule, a new target.
    Quadros AU, Cunha TM.
    Pharmacol Res; 2016 Oct; 112():58-67. PubMed ID: 26855316
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A key role of C5a/C5aR activation for the development of sepsis.
    Riedemann NC, Guo RF, Ward PA.
    J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
    [Abstract] [Full Text] [Related]

  • 6. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
    Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C, Explore COVID-19 IPH group, Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E.
    Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of C5a-C5aR axis in the development of atherosclerosis.
    An G, Ren G, An F, Zhang C.
    Sci China Life Sci; 2014 Aug; 57(8):790-4. PubMed ID: 25104451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
    Woodruff TM, Shukla AK.
    Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.
    Senent Y, Inogés S, López-Díaz de Cerio A, Blanco A, Campo A, Carmona-Torre F, Sunsundegui P, González-Martín A, Ajona D, Okrój M, Prósper F, Pio R, Yuste JR, Tavira B.
    Front Immunol; 2021 Nov; 12():767376. PubMed ID: 34868021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d.
    Kowalska D, Kuźniewska A, Senent Y, Tavira B, Inogés S, López-Díaz de Cerio A, Pio R, Okrój M, Yuste JR.
    Front Immunol; 2022 Nov; 13():946522. PubMed ID: 36091057
    [Abstract] [Full Text] [Related]

  • 17. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S, Najafi H, Shojaei F, Chi G, Goudarzi S, Sharfaei S, Kahe F, Hassanzadeh S.
    Infez Med; 2021 Mar 01; 29(1):1-9. PubMed ID: 33664168
    [Abstract] [Full Text] [Related]

  • 18. Function, structure and therapeutic potential of complement C5a receptors.
    Monk PN, Scola AM, Madala P, Fairlie DP.
    Br J Pharmacol; 2007 Oct 01; 152(4):429-48. PubMed ID: 17603557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
    Ghosh M, Rana S.
    Int Immunopharmacol; 2023 May 01; 118():110081. PubMed ID: 36989901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.